Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Continuum Health Ventures (CHV) is an early-stage venture capital fund based globally, with a focus on Healthtech, Techbio, and Healthspan Extension startups. Founded to support innovative healthcare solutions, CHV targets pre-seed to seed-plus stages and has a diverse portfolio across the United States, Canada, the Middle East, India, Japan, South Korea, and Singapore.
CHV invests in startups that digitize healthcare and improve health outcomes, particularly those emphasizing personalized interventions and the potential to reverse aging-related diseases. Their investment range includes pre-seed, seed, and seed-plus stages, with check sizes tailored to early-stage funding needs.
Notable portfolio companies include Ampa Health, which democratizes access to neurotechnology tools for brain disorders; Sanctuary AI, focused on creating highly dexterous mobile robots with General Machine Intelligence; Biotia, utilizing AI for rapid precision infectious disease discovery; Immunis, developing biologics for age-related conditions; and Cardiatech Bio, discovering novel cardiovascular therapeutics through multiomics.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.